Chill Brands Share Discussion Threads

[kemche] 16/8/2021 16:56

UJ9, That high? Brave call!

[ultimatejustice9] 16/8/2021 15:59

What price will you close A? I think fair value here is about 10p

[theanalyst1] 16/8/2021 11:14

standard operating practice for EchoRamp - lots of intimations he knows lots more than the general public followed by threats of the need to be careful, we don't know what's coming, don't be short, etc etc. zzzzzzzz ramblings of a fantasist puffing on a lead ballon

[kemche] 16/8/2021 10:48

And yet another second mover advantage entrant to the market:



But we have the first mover advantage so there is that.

And Slovakia.

[bbmsionlypostafter] 16/8/2021 10:24

It's 'cos of the name change. It's increased demand for the shares (& products!) enormously.

[kemche] 16/8/2021 10:22

Could only manage to buy one lot of 10k so far today.

[bbmsionlypostafter] 16/8/2021 09:34

echoridge
15 Aug '21 - 19:13 - 9514 of 9528


" oh and by the way, old toothless better watch himself as he attempts to 'contact AATAC'. playing with fire....."

echo, what do you mean by that? Will ZOE break his legs?

[terminator101] 16/8/2021 07:34

Change of name, that'll get em buying huh

[david gruen] 16/8/2021 07:26

16/08/2021 7:00am
UK Regulatory (RNS & others)

Cellular Goods (LSE:CBX)
Intraday Stock Chart

Monday 16 August 2021


RNS Number : 6698I

Cellular Goods PLC

16 August 2021

Press release

16 August 2021

Cellular Goods PLC

("Cellular Goods" or "the Company")

Multiyear supply agreement signed for launch of ingestible products

Cellular Goods (LSE: CBX), a UK-based provider of premium consumer products formulated with lab-made cannabinoids, is pleased to announce a multi-year manufacture and supply agreement with Chanelle McCoy Health Ltd (CMH) bringing forward its launch of a range of clinically-validated ingestible products to Q4 2021.

Under the agreement, CMH, a research-led developer of high quality ultra pure cannabinoid (CBD) products that are fully compliant with the new novel food regime, will initially supply three CBD ingestibles which will go on sale under the Cellular Goods brand in the UK, followed by continental Europe in 2022.

The deal marks a significant step in Cellular Goods' go-to-market strategy and will accelerate its entry into the market for ingestible wellness products for human consumption by more than a year.

These products will be introduced in mid-December at the same time as the Company's inaugural skincare range incorporating cannabigerol (CBG), and ahead of the new season product launches typically made in the wellness sector during the first quarter of a new year. The Company will initially sell the ingestible range exclusively through its new ecommerce website, which is in the latter stages of build and deployment.

A third line-up of "movement" products for both the athletic and everyday muscle recovery market is due to be launched in Spring 2022.

Key benefits of the deal include:

-- Immediate entry into the most developed market segment with early revenue generation opportunity.

-- Expands Cellular Goods' branded product range into a complementary market segment.
-- Provides access to a range of novel-food regulation compliant products which are ready for launch.

-- Reduced upfront R&D expenditure for market entry in ingestibles.
-- Opportunity for future product development and research collaborations through access to compliant ultra pure CBD and pharmaceutical expertise.

At launch the ingestible range will comprise a tincture, spray, and capsules covering the most popular modes of consumption. These have already passed extensive quality, safety and stability tests, comply with novel foods regulations in the UK and EU and are certified under Good Manufacturing Practice (GMP) standards. They contain lab-made CBD obtained through a GMP-certified process whereby naturally derived raw materials are converted to non-psychoactive ultra pure CBD that is bioidentical to plant-derived CBD but devoid of the many contaminants commonly found in plant-extracts, including pollutants, toxins, terpenes, heavy metals, pesticides, and psychoactive substances.

-- According to the Association for the Cannabinoid Industry (ACI) the UK has the world's most developed regulatory framework for legal cannabinoids and this market is estimated to be worth GBP690 million in 2021, making it the second largest in the world after the US.

-- The market for ingestible CBD products has seen strong growth following the European Commission's ruling that CBD is not considered a narcotic under the United Nations Single Convention on Narcotic Drugs of 1961.

-- Similarly, the World Anti Doping Agency has removed CBD from its list of prohibited substances, enabling use by professional and amateur athletes. The World Health Organization has also stated that CBD is "generally well-tolerated with a good safety profile".

Alexis Abraham, Cellular Goods' Chief Executive Officer, said: "Chanelle McCoy Health was founded by pharmaceutical industry veterans who share our vision that consumers have a right to expect products which are safe, pure, clean and green; something lab-made cannabinoids alone can guarantee. Through this partnership we will be introducing consumers to novel food compliant CBD ingestibles that will complement our CBG skincare range. As a result we will launch this year with both CBD and CBG and two best in class product ranges; one of which is substantially earlier than we expected."

Lady McCoy, Chief Executive and Co-Founder of Chanelle McCoy Health, added: "We are very excited to announce this commercial supply agreement of our ultra pure CBD. Consumers are searching for safe, certified, and reputable CBD products that are backed by clinical studies. This partnership will provide them choice and access to quality-assured CBD products containing 0% THC, an illegal narcotic, and free from toxins and pollutants. Cellular Goods and Chanelle McCoy Health are aligned in our pursuit to help break the stigma of CBD, educate and set the benchmark for the CBD industry."

[theanalyst1] 16/8/2021 02:43

well me old Ramp the only difference is that it's 11pm on a Sunday night for you which makes is rather sad that you are in the one bed sit engaging with strangers - surely the x files is on?. Curtesy of your fantastically orchistrated ramping syndicate last year, you managed to turn a start up with no track record and a two person team into a company worth £250m. I've done my work to understand it's still a start up with little to show and have shorted it aggressively. As it's collapsing that allows me to be in a hot country many hours time difference to you, toying with you from the beach and about to go to dinner...which as you are on the wrong side of the trade to me, you will be essentially paying for....repeatedly...all the way to sub 10p. Hope that Is that clear for you too?

[theanalyst1] 15/8/2021 22:58

Echo you do make a good point - in addition to all the money squandered on death spiral exits, the Chill domain name, Rodeo marketing, they also likely are blowing perhaps a million quid for Novel Foods. Unlike any other product that can just be sold, if you want to play in CBD then you must have novel foods - consider it a large tax to be allowed to the start line. So you had better make some serious sales to cover that cost on top of all other costs and then to make profits which is kind of what is needed to deliver some earnings across which to divide 220m shares to work out an EPS on which investors can better value a company. So with Zoetic having been plugging it's products in the Uk for over a year now i'm very excited to see what sales the brand has generated especially relative the the large costs it's paid as Ramp points out. As he is writing the RNS he will have first sight but for the rest of us the wait won't be long. I predict absolutely did all sales across the 21 SKUs in UK

[theanalyst1] 15/8/2021 22:51

echo you and Bo seem to have a very strange fascination about Winny and men's rectums....multiple posts each day on such matters suggests some underlying mental issues you both seem to have. Perhaps some professional help would be of benefit to you both...and everyone else on the boards here so we don't have to listen to these perversions daily!

[echoridge] 15/8/2021 21:36

f-ing A it is, kimmy. Since you and your masters are such experts in the FCA, why don't you check on the size, scope and cost of zoe's novel food submission and compare it the average company's. And while you're at it, have one of your fellow tools check in with their insiders at the FDA so they can learn him how the Americans are waiting for the FCA's guidance and maybe you'll start to appreciate that zoe is exactly as I've described. Then, the next time you've got your nose up winny's rectum, you can tell him about all of that just as he's about squeeze one out, and double your pleasure.

[kemche] 15/8/2021 21:08

"this company is a rule maker, not a rule breaker"

Too true Barry. The entire history of it shows that quite clearly.

20ks tomorrow or 10ks?

[echoridge] 15/8/2021 19:48

there should be a law.....

[bbmsionlypostafter] 15/8/2021 18:54

I can reveal that despite covering up industrial scale breaches of FDA Regulations after I published the damning 60 red flag dossier, the fraudsters at Zoetic (ZOE) continue to breach FDA guidelines as they try, and fail, to sell material quantities of CBD products via AATAC. I have alerted the FDA to this rule breach and wonder how AATAC will respond if it gets roped into any investigation? I shall also be contacting it this week...

[barn06048847] 15/8/2021 18:02

Shorts seem desperate to focus on the results and past performance, but the market will look forward. Much of the interesting developments have come post of the upcoming reported period. Forward looking statements should be really interesting.Zoe now profitable in 2k stores and in well over 2.5k stores now, and we've been told in the recent rns this rollout is to accelerate in coming months! Huge marketing push going on in the Rodeo space and through PBR which is huge for the exact demographic and customer base that Chill wants to capture.New CHILL.com domain is a stunning purchase for all the online doors it opens and marketing that can come with that!UK coming into focus now for Chill also and Zoetic may well about to be purchased for a nice sun! Yeah

[terminator101] 14/8/2021 10:19

And tiny cap? Hilarious. This had a mcap of over £200 million at one point.

[terminator101] 14/8/2021 10:18

Liquidity in a spread bet. You should really just stop now mate before you put the other foot in your gob